Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia
- 24 January 2003
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 253 (2) , 161-168
- https://doi.org/10.1046/j.1365-2796.2003.01070.x
Abstract
De Sauvage Nolting PRW, Defesche JC, Buirma RJA, Hutten BA, Lansberg PJ, Kastelein JJP (Academic Medical Center, Amsterdam; Clinical Research, Haarlem; Slotervaart Hospital, Amsterdam; the Netherlands). Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia. J Intern Med 2003; 253: 161–168. Objective. Patients with familial hypercholesterolaemia (FH) vary widely in terms of onset of cardiovascular disease (CVD). Design. The association between cardiovascular risk factors and prevalent CVD was examined in a cross‐sectional study in order to elucidate their contribution to atherogenesis. Setting and subjects. Patients were recruited from 37 Dutch Lipid Clinics. The diagnosis of FH was based on a uniform diagnostic protocol, confirmed by DNA analysis in 62% of the cases. All patients were investigated free from any lipid‐lowering drug for at least 6 weeks. Main outcome measures. Differences in lipids, lipoproteins and other risk factors for CVD were analysed in FH patients with and without CVD. Results. A total of 526 patients were assessed and more than 37% had a history of CVD with a mean age of onset of 46.8 years. Mean LDL cholesterol (LDL‐C) levels were severely elevated (8.38 ± 2.13 mmol L−1). In univariate analysis, age, presence of hypertension or diabetes, body mass index, triglycerides (TG) and low HDL cholesterol (HDL‐C) were all significantly associated with CVD. Also in multivariate analysis, all these risk factors, except TG and diabetes, were significantly linked to CVD. Conclusion. A high CVD risk in this large well‐documented characterized sample of FH patients is not only conferred by elevated LDL‐C but also by low HDL‐C.Keywords
This publication has 39 references indexed in Scilit:
- Baseline lipid values partly determine the response to high-dose simvastatin in patients with familial hypercholesterolemiaAtherosclerosis, 2002
- The molecular basis of familial hypercholesterolemia in The NetherlandsHuman Genetics, 2001
- Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemiaPublished by Oxford University Press (OUP) ,2001
- Mechanisms Regulating LDL Metabolism in Subjects on Peroral and Transdermal Estrogen Replacement TherapyArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Carotid and Femoral Artery Wall Thickness and Stiffness in Patients at Risk for Cardiovascular Disease, With Special Emphasis on HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Phenotypic Variation in Heterozygous Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Familial Hypercholesterolemia in the Finnish North KareliaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemiaThe Lancet, 1990